BioLargo, Inc. BLGO
$0.09
$0.00-1.97%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -271.63% | -310.26% | -390.42% | -364.86% | -40.22% |
| Total Depreciation and Amortization | 54.15% | 44.48% | 59.22% | 21.74% | 5.99% |
| Total Amortization of Deferred Charges | 289.55% | 721.43% | -- | -- | -- |
| Total Other Non-Cash Items | 5,128.13% | 2,157.42% | 709.81% | 240.74% | -103.41% |
| Change in Net Operating Assets | 105.68% | 77.77% | 35.11% | -412.05% | -3,604.50% |
| Cash from Operations | -37.92% | -70.09% | -158.80% | -567.41% | -1,373.23% |
| Capital Expenditure | -1,600.00% | 79.03% | 96.28% | 99.43% | 99.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 162.73% | 686.59% | 686.59% | -- | -- |
| Cash from Investing | -46.88% | 188.77% | 133.03% | 127.81% | 106.11% |
| Total Debt Issued | 54.90% | 112.52% | 48.73% | 3,246.15% | 3,246.15% |
| Total Debt Repaid | -840.00% | 69.23% | 100.00% | -146.51% | -142.86% |
| Issuance of Common Stock | 36.86% | 92.71% | 27.73% | 25.75% | 79.53% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -353.30% | -35.00% | -- | -100.00% | -70.50% |
| Cash from Financing | 48.49% | 149.82% | 85.24% | 145.66% | 80.75% |
| Foreign Exchange rate Adjustments | -107.69% | 72.73% | -125.53% | 150.72% | 148.75% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.85% | 187.92% | 3,622.22% | -20.95% | -208.74% |